Braun SpaceControl Manuel utilisateur

for automated glucose control
Instructions for use
Valid for software I93050A
SpaceControl
g

2
Contents
Contents
1 About this document........................................................................................4
1.1 Purpose ......................................................................................................................... 4
1.2 Additional valid instructions for use .................................................................... 4
1.3 Markings and symbols .............................................................................................. 4
1.4 Abbreviations .............................................................................................................. 4
2 Safety instructions ...........................................................................................5
2.1 Intended use ............................................................................................................... 5
2.2 Safe handling of the device .................................................................................... 5
2.3 Safe application of the automated glucose monitoring ................................ 7
2.4 Other components ..................................................................................................... 8
2.5 Safety standards ........................................................................................................ 8
3 Description of the device .................................................................................9
3.1 Displays and controls ................................................................................................ 9
3.2 Interfaces ...................................................................................................................10
3.3 Symbols on the device ...........................................................................................10
3.4 Application of the automated glucose monitoring .........................................11
3.4.1 Positioning of the device within the SGC system /
compatible components .............................................................................11
3.4.2 Tasks of the device within the SGC system ..........................................12
4 Description of the functions / Operation .................................................... 13
4.1 Screen design ............................................................................................................13
4.1.1 Overview screen (example) .......................................................................14
4.1.2 Display of alarm states ...............................................................................15
4.2 Navigation and input elements ...........................................................................16
5 Menu structure / Overview of functions .................................................... 18
5.1 Main menu ................................................................................................................18
5.2 Nutrition .....................................................................................................................18
5.3 Options........................................................................................................................19
5.3.1 Options > Patient data ...............................................................................19
5.3.2 Options > System Data > System Data .................................................19
5.3.3 Options > System Data > SpaceCom .....................................................20
5.3.4 Options > Conguration SGC ...................................................................20
5.3.5 Options > Conguration SpaceControl .................................................21
5.4 Start / Stop and Overview .....................................................................................21
6 Start-up and self-test................................................................................... 22

3
Contents
7 Operation ...................................................................................................... 23
7.1 Starting a new therapy ..........................................................................................23
7.2 Calculation of new suggested values ................................................................26
7.2.1 Hypoglycaemia warning ...........................................................................27
7.2.2 Blood glucose value is not plausible .....................................................27
7.2.3 Error in calculation .....................................................................................27
7.3 Conrming the suggested insulin dose rate / SGC mode.............................28
7.4 Entering the blood glucose value ........................................................................28
7.5 Overruling the insulin dose rate / manual mode ............................................29
7.6 Returning to the SGC mode ..................................................................................30
7.7 Changing the nutrition rate (enteral / parenteral) ........................................30
7.8 Stopping nutrition (enteral / parenteral) / interrupting
for short period ........................................................................................................30
7.9 Entering parenteral bolus ...................................................................................... 31
7.10 Entering a meal ........................................................................................................31
7.11 Enabling standby mode on the device as well as insulin and
nutrition pumps .......................................................................................................32
7.12 Data Lock ...................................................................................................................32
7.13 Displaying the insulin pump settings .................................................................32
7.14 Displaying the nutrition pump settings (enteral / parenteral) ...................33
7.15 Stopping the insulin pump ....................................................................................33
7.16 Ceasing the therapy ................................................................................................34
7.17 Continuing the therapy ..........................................................................................34
7.18 Starting a new therapy after a therapy has been ceased ............................34
7.19 Steps to be taken if the SGC therapy does not start .....................................35
8 Alarms .......................................................................................................... 37
9 Cleaning and care / Disposal ........................................................................ 38
9.1 Cleaning and care ....................................................................................................38
9.2 Disposal ......................................................................................................................38
10 Technical Safety Check (TSC) / Service ....................................................... 39
11 Guarantee ...................................................................................................... 39
12 Technical data ................................................................................................ 40
13 Instructions on electromagnetic compatibility (EMC)............................... 41
14 Order data ...................................................................................................... 43
Contents
1 About this document........................................................................................4
1.1 Purpose ......................................................................................................................... 4
1.2 Additional valid instructions for use .................................................................... 4
1.3 Markings and symbols .............................................................................................. 4
1.4 Abbreviations .............................................................................................................. 4
2 Safety instructions ...........................................................................................5
2.1 Intended use ............................................................................................................... 5
2.2 Safe handling of the device .................................................................................... 5
2.3 Safe application of the automated glucose monitoring ................................ 7
2.4 Other components ..................................................................................................... 8
2.5 Safety standards ........................................................................................................ 8
3 Description of the device .................................................................................9
3.1 Displays and controls ................................................................................................ 9
3.2 Interfaces ...................................................................................................................10
3.3 Symbols on the device ...........................................................................................10
3.4 Application of the automated glucose monitoring .........................................11
3.4.1 Positioning of the device within the SGC system /
compatible components .............................................................................11
3.4.2 Tasks of the device within the SGC system ..........................................12
4 Description of the functions / Operation .................................................... 13
4.1 Screen design ............................................................................................................13
4.1.1 Overview screen (example) .......................................................................14
4.1.2 Display of alarm states ...............................................................................15
4.2 Navigation and input elements ...........................................................................16
5 Menu structure / Overview of functions .................................................... 18
5.1 Main menu ................................................................................................................18
5.2 Nutrition .....................................................................................................................18
5.3 Options........................................................................................................................19
5.3.1 Options > Patient data ...............................................................................19
5.3.2 Options > System Data > System Data .................................................19
5.3.3 Options > System Data > SpaceCom .....................................................20
5.3.4 Options > Conguration SGC ...................................................................20
5.3.5 Options > Conguration SpaceControl .................................................21
5.4 Start / Stop and Overview .....................................................................................21
6 Start-up and self-test................................................................................... 22

4
About this document
1 About this document
1.1 Purpose
These instructions for use are part of the device.
Read these instructions for use before starting up.
Always keep the instructions for use available with the device.
Read and observe all additional valid instructions for use.
1.2 Additional valid instructions for use
Instructions for use Information
Perfusor®Space Safe operation of the infusion pump
Infusomat®Space Safe operation of the volumetric pump
SpaceStation Use and removal of the pump and the device
SGC module Mounting of the SGC module onto the device
1.3 Markings and symbols
Marking Meaning
WARNING! Instruction to prevent dangers to the patient or the user
Attention: Instruction to prevent damage to the device or operating
error
Note: Information to better understand or to optimize work
processes
Handling instruction: You must do something here.
1. Handling instruction for several steps.
2. Observe the correct order.
Bold print Refers to a navigation or input element
Button > Button Press the buttons indicated in the order given.
1.4 Abbreviations
Abbreviation Meaning
SGC Space GlucoseControl

5
Safety instructions
2 Safety instructions
2.1 Intended use
SGC is a decision supporting system for optimised insulin therapy for critically
ill patients in a closely monitored environment, e. g. intensive care units (ICU)
or operating theatres. Based on the data of patient's glucose level and optional
carbohydrate feeding coming from enteral and parenteral nutrition pumps the
system suggests an insulin dose rate.
The medical expert then decides on the applicability of the insulin dose rate
suggested.
Additional descriptions are contained in these instructions for use.
2.2 Safe handling of the device
Initial training at the device must be carried out by the sales sta of B. Braun
or another authorised person. The user is instructed to inform himself of the
most recent changes to the device and its additional equipment after each
software update. These details are in the instructions for use.
Do not use the device in potentially explosive areas such as, in operating
theatres, when ammable anaesthetic gases are used.
Only use the device under regular control by trained personnel.
The system must have a sure footing during operation or must be xed by a
suitable tool to a stand or a wall mount.
The system – especially the terminal block contacts and the connection
cable – and the patient must not be touched simultaneously.
The device can only be used together with an insulin pump; it does not have
an independent power supply.
Do not remove the insulin pump above the device. The device would then
loose its power supply and all stored values would be lost.
If the mains supply fails then the battery from the insulin pump located
above it supplies the device with power. Running the insulin pump on
batteries can therefore shorten the operating time.
Do not switch o the insulin pump above the device if the mains supply
fails. The device would then loose its power supply and all stored values
would be lost.
Make sure that the device is correctly positioned and secured. Do not
position the device above the patient.
Before starting up the device, check for any damages or missing parts.
Installation in medically used rooms must comply with the appropriate
regulations (e.g. VDE 0100, VDE 0107 or IEC-publications). Observe all
national regulations and deviations from these instructions.

6
Protect the device from moisture.
If the device is dropped / falls, or subjected to shock, then it must be
checked by the service workshop.
The device and the patient must not be touched simultaneously.
If the device is stored in temperature areas below the dened operating
conditions then allow the device to sit for at least one hour at room
temperature before starting it up.
When used for mobile applications (homecare, transporting patients within
and outside the clinic) secure the device and the insulin pump with the
supplied xing clip and lock the control panel.
Make sure that the software version on the device is the same as the
software version referred to in these instructions for use (see title page).
If there are contradictory or dubious values displayed on the device and the
pump, then only those values displayed on the pump are valid.
Always check the plausibility of the values displayed before making any
further medical decisions.
Check optical alarms and displays during the self-test.
The device is subject to special safety measures with regard to
electromagnetic compatibility (EMC). Observe the electromagnetic
compatibility (EMC) instructions during installation and operation
(see Chapter 13, P. 41).
The device can be inuenced by mobile HF communication equipment
(e.g. mobile phones, radios).
The device must be operated at a sucient distance from other electrical
devices. An exception to this is operation of the device in a SpaceStation
together with several insulin and nutrition pumps. Otherwise, function in
accordance to the instructions must be checked.
The use of additional equipment not intended for use with the device may
result in increased emission or a reduction in the immunity of the device.
The device's functions may be impaired by the use of devices with high
electromagnetic radiation (e.g. mobile / cordless phones, X-ray machines,
HF surgical apparatus). In these cases, the displayed values may be incorrect.
When using in the environment of devices that may increase emitted
interference (e.g. HF surgical apparatus, MRT, mobile phones), observe the
safety clearances recommended for the device.
Safety instructions

7
2.3 Safe application of the automated glucose monitoring
The SGC system may only be used by persons who have been trained for use
of the system and who are experienced in the insulin therapy of critically ill
patients.
The values displayed on the system are insucient to make therapeutic or
diagnostic decisions regarding the condition of the patient. The device is
only a tool and does not replace monitoring / control by medical personnel.
As in all therapies, interactions with other medication must be considered
during insulin therapy with this device.
Changes of the insulin dose may inuence the potassium level of the patient.
During an insulin therapy it therefore is necessary to regularly check the
potassium level.
Check whether the entered values really are the same as the displayed
values in order to detect typing errors and to prevent incorrect entries. Only
start infusion when the values are identical.
The blood glucose measuring device used must be validated for use in an
intensive care unit.
The insulin and nutrition pumps used in the system can be controlled (and
stopped) at all times from their control panels.
Entering an incorrect blood glucose value has a long term eect on the SGC
algorithm even if the correct value is subsequently entered. Never enter
incorrect values, e.g. for test purposes. Check all entries carefully before
conrming them.
When calculating the new suggested values by the SGC algorithm, only the
current rates of the nutrition pumps (enteral / parenteral) contained in the
system are automatically considered. Enter additional parenteral boluses
and feeds for the patient manually at the device.
When calculating the new suggested values by the SGC algorithm, only
the insulin pump contained in the system is automatically considered. Any
additional administration of insulin is forbidden.
When treating forms of hypoglycaemia when using the system, always
consider the current state of medical knowledge and the local standards.
If the insulin pump stops due to a pressure alarm or a syringe change, it is
recommended to reduce the time until the next blood glucose measurement
to the minimum of 30 minutes.
Safety instructions

8
2.4 Other components
Please observe the instructions for use of the other components with regard
to their technical data.
Possible incompatibilities of devices and drugs are contained in the
respective information from the manufacturer.
Only use compatible combinations of devices, additional equipment and
wearing parts.
Connected electrical components must comply with the IEC/EN specication
(e.g. IEC/EN 60950 for data-processing devices). Anyone connecting
additional devices must be system installer and is therefore responsible for
compliance to system standard IEC/EN 60601-1-1.
2.5 Safety standards
The device meets all safety standards for medical electrical equipment in
compliance with IEC/EN 60601-1 and IEC/EN 60601-2-24.
EMC thresholds (electromagnetic compatibility) compliant to
IEC/EN 60601-1-2 and IEC/EN 60601-2-24 are observed.
The device complies with the appropriate requirements of DIN EN 1789 for
use in Medical Vehicles and their equipment.
Safety instructions

9
3 Description of the device
3.1 Displays and controls
No. Name / Function
1 Control panel: Display / Touch screen for entries
Can be released easily with slight pressure and then pulled out; locks
into position when pushed in
Can be adjusted and locked at various viewing angles
2 Control panel lock / Mouse pen for touch screen entry
Control panel can be locked and unlocked
Control panel must be locked during mobile use
Lock can be pulled out and used as a mouse pen
Mouse pen must lock in position when inserted to allow the
control panel to be pushed in
3 Blue LED: Lights when SGC mode is active
Description of the device

10
3.2 Interfaces
No. Symbol Interface
1 – To insulin pump for power supply and data communication
2 For expansions, e.g. SGC module
3 Without function in this software version
4 – Infrared (IrDA)
3.3 Symbols on the device
Symbol Meaning
Attention! Observe accompanying documents.
Observe disposal instructions.
Type CF debrillator-protected part
The device has increased protection against electrical
shock, especially with regard to operating currents
Protection class II device
The device does not require an earth conductor
CE mark compliant to Directive 93/42/EEC
Description of the device
Table des matières
Manuels Équipement de laboratoire populaires d'autres marques

Agilent Technologies
Agilent Technologies 5800 ICP-OES Manuel utilisateur

Endress+Hauser
Endress+Hauser Cleanfit CPA875 Manuel utilisateur

NI
NI PXI-5422 Manuel

Collomix
Collomix Aqix Manuel utilisateur

SPEX SamplePrep
SPEX SamplePrep 6875 Freezer/Mill Series Manuel utilisateur

Ocean Insight
Ocean Insight FLAME-NIR+ Manuel utilisateur











